S
Sally P. Stenning
Researcher at Medical Research Council
Publications - 99
Citations - 11978
Sally P. Stenning is an academic researcher from Medical Research Council. The author has contributed to research in topics: Cancer & Testicular cancer. The author has an hindex of 38, co-authored 98 publications receiving 10817 citations. Previous affiliations of Sally P. Stenning include University of Manchester & Emory University.
Papers
More filters
Journal ArticleDOI
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
David Cunningham,William H. Allum,Sally P. Stenning,Jeremy Thompson,Marianne Nicolson,J. Howard Scarffe,F. Lofts,Stephen Falk,Timothy Iveson,David Smith,Ruth E Langley,Monica Verma,Simon Weeden,Yu Jo Chua +13 more
TL;DR: In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival.
Journal ArticleDOI
Long-Term Results of a Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer
TL;DR: Long-term follow-up confirms that preoperative chemotherapy improves survival in operable esophageal cancer and should be considered as a standard of care.
Journal ArticleDOI
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial
R.T.D. Oliver,Mason,Graham M. Mead,H. von der Maase,Gordon J. S. Rustin,Johnathan Joffe,R. de Wit,Nina Aass,John Graham,Robert E. Coleman,S.J. Kirk,Sally P. Stenning +11 more
TL;DR: This trial has shown the non-inferiority of carboplatin to radiotherapy in the treatment of stage I seminoma, although the absence of disease-related deaths and preliminary data indicating fewer second primary testicular germ-cell tumours favourcarboplatin use, these findings need to be confirmed beyond 4 years' follow-up.
Journal ArticleDOI
Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer study 22845 with the Medical Research Council study BRO4: An interim analysis
A.B.M.F. Karim,D Afra,Philippe Cornu,Norman Bleehan,S. Schraub,Olivier De Witte,François Darcel,Sally P. Stenning,Marianne Pierart,Martine Van Glabbeke +9 more
TL;DR: Early postoperative conventional RT such as that used for this protocol appears to improve the time to progression or progression-free survival, but not overall survival, for patients with low-grade glioma.
Journal ArticleDOI
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.
Alan Horwich,D. T. Sleijfer,Sophie D. Fossa,S. B. Kaye,R. T.D. Oliver,Michael Cullen,GM Mead,R. de Wit,P.H.M. de Mulder,David P. Dearnaley,P. A. Cook,Richard Sylvester,Sally P. Stenning +12 more
TL;DR: This prospective randomized multicenter trial was designed to evaluate the efficacy of carboplatin plus etoposide and bleomycin (CEB) versus cisplatin plus Etoposid and bleoniccin (BEP) in first-line chemotherapy of patients with good-risk nonseminomatous germ cell tumors.